tiprankstipranks
Abcellera Biologics, Inc. (ABCL)
NASDAQ:ABCL
ABCL
AbCellera Biologics
RESEARCH TOOLSreports
Want to see ABCL full AI Analyst Report?

AbCellera Biologics (ABCL) Revenue

2,381 Followers
StatisticsMarket CapRevenue

AbCellera Biologics Revenue

AbCellera Biologics had a revenue of 8.31M in the quarter ending Mar 31, 2026, with -81.46%. This bring the company's revenue in the last twelve months to 79.21M, Decreased 5.43%. In the fiscal year ending Dec 31, 2025, AbCellera Biologics had annual revenue of 75.13M with 160.56% growth.
Revenue (ttm)
79.21M
Revenue Growth
242.66%
P/S Ratio
22.88
Revenue/Employee
$126,054
Employees
596
Market Cap
$1.72B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
75.13M46.30M+160.56%
Dec 31, 2024
28.83M-9.19M-24.17%
Dec 31, 2023
38.02M-447.40M-92.17%
Dec 31, 2022
485.42M110.22M+29.38%
Dec 31, 2021
375.20M142.05M+60.92%
Dec 31, 2020
233.16M221.54M+1,907.88%
Dec 31, 2019
11.61M2.78M+31.49%
Dec 31, 2018
8.83M――